Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation

Paolo Fiorina, Franco Folli, Armando D'Angelo, Giovanna Finzi, Fabio Pellegatta, Valeria Guzzi, Carlo Fedeli, Patrizia Della Valle, Luciana Usellini, Claudia Placidi, Francesco Bifari, Daniela Belloni, Elisabetta Ferrero, Carlo Capella, Antonio Secchi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

To evaluate the effects of kidney-pancreas transplantation on hemostatic abnormalities in uremic type 1 diabetic patients, we conducted a cross-sectional study involving 12 type 1 diabetic patients, 30 uremic type 1 diabetic patients, 27 uremic type 1 diabetic patients who had a kidney-pancreas transplant, 12 uremic type 1 diabetic patients who had a kidney-alone transplant, and 13 healthy control subjects. We evaluated platelet and clotting system. Platelets in the group of uremic type 1 diabetic patients were significantly larger than platelets in the other groups. Resting calcium levels were significantly higher in the uremic type 1 diabetic patients and uremic type 1 diabetic patients who had a kidney-alone transplant than in the type 1 diabetic patients who had a kidney-pancreas transplant and control subjects. CD41 expression was significantly reduced in platelets from the uremic type 1 diabetic patients compared with the other groups. Levels of hypercoagulability markers in the type 1 diabetic patients who had a kidney-pancreas transplant and, to a lesser extent, the uremic type 1 diabetic patients who had a kidney-alone transplant but not the uremic type 1 diabetic patients were similar to those of the control subjects. A reduction in natural anticoagulants was evident in the uremic type 1 diabetic patients, whereas near-normal values were observed in the type 1 diabetic patients who had a kidney-pancreas transplant and uremic type 1 diabetic patients who had a kidney-alone transplant. Hemostatic abnormalities were not observed in type 1 diabetic patients who had a kidney-pancreas transplant. This finding might explain the lower cardiovascular death rate observed in type 1 diabetic patients who had a kidney-pancreas transplant compared with uremic type 1 diabetic patients who had a kidney-alone transplant or uremic type 1 diabetic patients.

Original languageEnglish (US)
Pages (from-to)2291-2300
Number of pages10
JournalDiabetes
Volume53
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Multiple Abnormalities
Pancreas Transplantation
Hemostatics
Kidney Transplantation
Transplants
Kidney
Pancreas
Blood Platelets

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Fiorina, P., Folli, F., D'Angelo, A., Finzi, G., Pellegatta, F., Guzzi, V., ... Secchi, A. (2004). Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes, 53(9), 2291-2300. https://doi.org/10.2337/diabetes.53.9.2291

Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. / Fiorina, Paolo; Folli, Franco; D'Angelo, Armando; Finzi, Giovanna; Pellegatta, Fabio; Guzzi, Valeria; Fedeli, Carlo; Della Valle, Patrizia; Usellini, Luciana; Placidi, Claudia; Bifari, Francesco; Belloni, Daniela; Ferrero, Elisabetta; Capella, Carlo; Secchi, Antonio.

In: Diabetes, Vol. 53, No. 9, 09.2004, p. 2291-2300.

Research output: Contribution to journalArticle

Fiorina, P, Folli, F, D'Angelo, A, Finzi, G, Pellegatta, F, Guzzi, V, Fedeli, C, Della Valle, P, Usellini, L, Placidi, C, Bifari, F, Belloni, D, Ferrero, E, Capella, C & Secchi, A 2004, 'Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation', Diabetes, vol. 53, no. 9, pp. 2291-2300. https://doi.org/10.2337/diabetes.53.9.2291
Fiorina, Paolo ; Folli, Franco ; D'Angelo, Armando ; Finzi, Giovanna ; Pellegatta, Fabio ; Guzzi, Valeria ; Fedeli, Carlo ; Della Valle, Patrizia ; Usellini, Luciana ; Placidi, Claudia ; Bifari, Francesco ; Belloni, Daniela ; Ferrero, Elisabetta ; Capella, Carlo ; Secchi, Antonio. / Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. In: Diabetes. 2004 ; Vol. 53, No. 9. pp. 2291-2300.
@article{bd468234960a4467b88f51e16188197e,
title = "Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation",
abstract = "To evaluate the effects of kidney-pancreas transplantation on hemostatic abnormalities in uremic type 1 diabetic patients, we conducted a cross-sectional study involving 12 type 1 diabetic patients, 30 uremic type 1 diabetic patients, 27 uremic type 1 diabetic patients who had a kidney-pancreas transplant, 12 uremic type 1 diabetic patients who had a kidney-alone transplant, and 13 healthy control subjects. We evaluated platelet and clotting system. Platelets in the group of uremic type 1 diabetic patients were significantly larger than platelets in the other groups. Resting calcium levels were significantly higher in the uremic type 1 diabetic patients and uremic type 1 diabetic patients who had a kidney-alone transplant than in the type 1 diabetic patients who had a kidney-pancreas transplant and control subjects. CD41 expression was significantly reduced in platelets from the uremic type 1 diabetic patients compared with the other groups. Levels of hypercoagulability markers in the type 1 diabetic patients who had a kidney-pancreas transplant and, to a lesser extent, the uremic type 1 diabetic patients who had a kidney-alone transplant but not the uremic type 1 diabetic patients were similar to those of the control subjects. A reduction in natural anticoagulants was evident in the uremic type 1 diabetic patients, whereas near-normal values were observed in the type 1 diabetic patients who had a kidney-pancreas transplant and uremic type 1 diabetic patients who had a kidney-alone transplant. Hemostatic abnormalities were not observed in type 1 diabetic patients who had a kidney-pancreas transplant. This finding might explain the lower cardiovascular death rate observed in type 1 diabetic patients who had a kidney-pancreas transplant compared with uremic type 1 diabetic patients who had a kidney-alone transplant or uremic type 1 diabetic patients.",
author = "Paolo Fiorina and Franco Folli and Armando D'Angelo and Giovanna Finzi and Fabio Pellegatta and Valeria Guzzi and Carlo Fedeli and {Della Valle}, Patrizia and Luciana Usellini and Claudia Placidi and Francesco Bifari and Daniela Belloni and Elisabetta Ferrero and Carlo Capella and Antonio Secchi",
year = "2004",
month = "9",
doi = "10.2337/diabetes.53.9.2291",
language = "English (US)",
volume = "53",
pages = "2291--2300",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation

AU - Fiorina, Paolo

AU - Folli, Franco

AU - D'Angelo, Armando

AU - Finzi, Giovanna

AU - Pellegatta, Fabio

AU - Guzzi, Valeria

AU - Fedeli, Carlo

AU - Della Valle, Patrizia

AU - Usellini, Luciana

AU - Placidi, Claudia

AU - Bifari, Francesco

AU - Belloni, Daniela

AU - Ferrero, Elisabetta

AU - Capella, Carlo

AU - Secchi, Antonio

PY - 2004/9

Y1 - 2004/9

N2 - To evaluate the effects of kidney-pancreas transplantation on hemostatic abnormalities in uremic type 1 diabetic patients, we conducted a cross-sectional study involving 12 type 1 diabetic patients, 30 uremic type 1 diabetic patients, 27 uremic type 1 diabetic patients who had a kidney-pancreas transplant, 12 uremic type 1 diabetic patients who had a kidney-alone transplant, and 13 healthy control subjects. We evaluated platelet and clotting system. Platelets in the group of uremic type 1 diabetic patients were significantly larger than platelets in the other groups. Resting calcium levels were significantly higher in the uremic type 1 diabetic patients and uremic type 1 diabetic patients who had a kidney-alone transplant than in the type 1 diabetic patients who had a kidney-pancreas transplant and control subjects. CD41 expression was significantly reduced in platelets from the uremic type 1 diabetic patients compared with the other groups. Levels of hypercoagulability markers in the type 1 diabetic patients who had a kidney-pancreas transplant and, to a lesser extent, the uremic type 1 diabetic patients who had a kidney-alone transplant but not the uremic type 1 diabetic patients were similar to those of the control subjects. A reduction in natural anticoagulants was evident in the uremic type 1 diabetic patients, whereas near-normal values were observed in the type 1 diabetic patients who had a kidney-pancreas transplant and uremic type 1 diabetic patients who had a kidney-alone transplant. Hemostatic abnormalities were not observed in type 1 diabetic patients who had a kidney-pancreas transplant. This finding might explain the lower cardiovascular death rate observed in type 1 diabetic patients who had a kidney-pancreas transplant compared with uremic type 1 diabetic patients who had a kidney-alone transplant or uremic type 1 diabetic patients.

AB - To evaluate the effects of kidney-pancreas transplantation on hemostatic abnormalities in uremic type 1 diabetic patients, we conducted a cross-sectional study involving 12 type 1 diabetic patients, 30 uremic type 1 diabetic patients, 27 uremic type 1 diabetic patients who had a kidney-pancreas transplant, 12 uremic type 1 diabetic patients who had a kidney-alone transplant, and 13 healthy control subjects. We evaluated platelet and clotting system. Platelets in the group of uremic type 1 diabetic patients were significantly larger than platelets in the other groups. Resting calcium levels were significantly higher in the uremic type 1 diabetic patients and uremic type 1 diabetic patients who had a kidney-alone transplant than in the type 1 diabetic patients who had a kidney-pancreas transplant and control subjects. CD41 expression was significantly reduced in platelets from the uremic type 1 diabetic patients compared with the other groups. Levels of hypercoagulability markers in the type 1 diabetic patients who had a kidney-pancreas transplant and, to a lesser extent, the uremic type 1 diabetic patients who had a kidney-alone transplant but not the uremic type 1 diabetic patients were similar to those of the control subjects. A reduction in natural anticoagulants was evident in the uremic type 1 diabetic patients, whereas near-normal values were observed in the type 1 diabetic patients who had a kidney-pancreas transplant and uremic type 1 diabetic patients who had a kidney-alone transplant. Hemostatic abnormalities were not observed in type 1 diabetic patients who had a kidney-pancreas transplant. This finding might explain the lower cardiovascular death rate observed in type 1 diabetic patients who had a kidney-pancreas transplant compared with uremic type 1 diabetic patients who had a kidney-alone transplant or uremic type 1 diabetic patients.

UR - http://www.scopus.com/inward/record.url?scp=4344651590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344651590&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.9.2291

DO - 10.2337/diabetes.53.9.2291

M3 - Article

C2 - 15331538

AN - SCOPUS:4344651590

VL - 53

SP - 2291

EP - 2300

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -